Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
||
| Revenues: | |||||
| Premiums | $ 24,657 | $ 21,003 | $ 74,117 | $ 63,894 | |
| Net investment income | 277 | 201 | 885 | 515 | |
| Total revenues | 89,764 | 81,159 | 263,963 | 238,621 | |
| Operating costs: | |||||
| Cost of products sold | 54,688 | 50,365 | 159,679 | 145,164 | |
| Health care costs | 21,499 | 17,401 | 63,729 | 52,814 | |
| Restructuring charges | 11 | 0 | 507 | 0 | |
| Opioid litigation charges | 0 | 5,220 | 0 | 5,704 | |
| Loss on assets held for sale | 0 | 2,480 | 349 | 2,521 | |
| Operating expenses | 9,876 | 9,612 | 29,329 | 28,123 | |
| Total operating costs | 86,074 | 85,078 | 253,593 | 234,326 | |
| Operating income (loss) | 3,690 | (3,919) | 10,370 | 4,295 | |
| Interest expense | 693 | 566 | 1,968 | 1,735 | |
| Other income | (22) | (41) | (66) | (126) | |
| Income (loss) before income tax provision (benefit) | 3,019 | (4,444) | 8,468 | 2,686 | |
| Income tax provision (benefit) | 754 | (1,045) | 2,147 | 691 | |
| Net income (loss) | 2,265 | (3,399) | 6,321 | 1,995 | |
| Net income attributable to noncontrolling interests | (4) | (7) | (23) | (18) | |
| Net income (loss) attributable to CVS Health | $ 2,261 | $ (3,406) | $ 6,298 | $ 1,977 | |
| Net income (loss) per share attributable to CVS Health: | |||||
| Basic (in dollars per share) | $ 1.76 | $ (2.59) | $ 4.90 | $ 1.51 | |
| Diluted (in dollars per share) | $ 1.75 | $ (2.59) | $ 4.88 | $ 1.49 | |
| Weighted average shares outstanding: | |||||
| Basic (in shares) | 1,287 | 1,315 | 1,284 | 1,313 | |
| Diluted (in shares) | 1,290 | 1,315 | 1,289 | 1,324 | |
| Dividends declared per share (in dollars per share) | $ 0.605 | $ 0.55 | $ 1.815 | $ 1.65 | |
| Cost, Product and Service [Extensible List] | Products | Products | Products | Products | |
| Products | |||||
| Revenues: | |||||
| Revenues | $ 61,298 | $ 57,643 | $ 179,984 | $ 166,959 | |
| Services | |||||
| Revenues: | |||||
| Revenues | $ 3,532 | $ 2,312 | $ 8,977 | $ 7,253 | |
| X | ||||||||||
- Definition Operating Expenses, Excluding Goodwill Impairments, Loss On Assets Held For Sale, And Loss On Litigation Settlement No definition available.
|
| X | ||||||||||
- Definition Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Indicates type of cost from product sold and service rendered. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|